Nonsteroidal antiinflammmatory medications and COVID-19
French health official recently suggested that nonsteroidal antiinflammmatory drugs (NSAIDS, e.g. ibuprofen, naproxen, Advil, Aleve) may have grave adverse events for those with COVID-19. The Spanish Ministry of Health responded by stating there is no compelling evidence to support that assertion. World Health Organization and multiple top physician-scientists throughout the United States have agreed that these are simply unproven anecdotal reports that do not provide compelling evidence to suggest NSAIDs may be harmful for those with COVID-19.
It is agreed that chronic NSAID use may be associated with kidney failure, hypertension, edema of the legs, gastric and duodenal ulcers, and possibly cardiovascular events. Acetaminophen, of note, is not thought to have any of the above risks.